AtriCure, Inc. (NASDAQ:ATRC) has scheduled a conference call for 5th November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.atricure.com
Earnings Expectation
AtriCure, Inc. is set to announce third quarter earning results on Thursday 5th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ATRC to report 3Q20 loss of $ 0.34 per share from revenue of $ 49.37 million. For the full year, analysts anticipate top line of $ 205.45 million, while looking forward to loss of $ 1.27 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 254.00 million ~ $ 261.00 million, where as bottomline are predicted in a range of $ -1.24 ~ $ -1.14 per share
Click Here For More Historical Outlooks Of AtriCure, Inc.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy.
